Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Insights and Forecast to 2031

Report ID: 1154491 | Published Date: Jan 2025 | No. of Page: 72 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 23-Valent Pneumococcal Polysaccharide Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Single Dose Vial
        1.2.3 Pre-filled Syringe
    1.3 Market by Application
        1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 For Children (2-10)
        1.3.3 For Person (10-64)
        1.3.4 For The Old (Above or equal to 65)
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Estimates and Forecasts 2017-2028
    2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Estimates and Forecasts 2017-2028
    2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
        2.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales 23-Valent Pneumococcal Polysaccharide Vaccine by Region (2023-2028)
    2.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region
        2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022)
        2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
        3.1.1 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine in 2021
    3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers
        3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2021
    3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
        4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Sales by Type (2023-2028)
        4.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type
        4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type
        4.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2017-2022)
        4.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
        5.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Sales by Application (2023-2028)
        5.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application
        5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application
        5.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2017-2022)
        5.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
        6.1.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
        6.1.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
    6.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
        6.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
        6.2.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
    6.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
        6.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2028)
        6.3.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
        7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
        7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
    7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
        7.2.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
        7.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
    7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
        7.3.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2028)
        7.3.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
        8.1.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
        8.1.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
    8.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
        8.2.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
        8.2.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
    8.3 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
        8.3.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2028)
        8.3.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
        9.1.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
        9.1.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
    9.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
        9.2.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
        9.2.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
    9.3 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
        9.3.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2028)
        9.3.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
        10.1.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
    10.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
        10.2.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
    10.3 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
        10.3.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 MSD
        11.1.1 MSD Corporation Information
        11.1.2 MSD Overview
        11.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 MSD Recent Developments
    11.2 Sanofipasteur
        11.2.1 Sanofipasteur Corporation Information
        11.2.2 Sanofipasteur Overview
        11.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Sanofipasteur Recent Developments
    11.3 CDIBP
        11.3.1 CDIBP Corporation Information
        11.3.2 CDIBP Overview
        11.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 CDIBP Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Chain Analysis
    12.2 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 23-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process
    12.4 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Marketing
        12.4.1 23-Valent Pneumococcal Polysaccharide Vaccine Sales Channels
        12.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
    12.5 23-Valent Pneumococcal Polysaccharide Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
    13.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
    13.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
    13.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
14 Key Findings in The Global 23-Valent Pneumococcal Polysaccharide Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Single Dose Vial
    Table 3. Major Manufacturers of Pre-filled Syringe
    Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Dose)
    Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
    Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2023-2028) & (K Dose)
    Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2023-2028)
    Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
    Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2023-2028)
    Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2017-2022) & (K Dose)
    Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers (2017-2022)
    Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 18. 23-Valent Pneumococcal Polysaccharide Vaccine Price by Manufacturers (2017-2022) &(US$/Dose)
    Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2021)
    Table 21. 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
    Table 23. Date of Manufacturers Enter into 23-Valent Pneumococcal Polysaccharide Vaccine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
    Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Dose)
    Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2017-2022)
    Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2023-2028)
    Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2017-2022)
    Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2023-2028)
    Table 33. 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2017-2022) & (US$/Dose)
    Table 34. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Type (2023-2028) & (US$/Dose)
    Table 35. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
    Table 36. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Dose)
    Table 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2017-2022)
    Table 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2023-2028)
    Table 39. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2017-2022)
    Table 42. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2023-2028)
    Table 43. 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2017-2022) & (US$/Dose)
    Table 44. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2023-2028) & (US$/Dose)
    Table 45. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
    Table 46. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Dose)
    Table 47. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
    Table 50. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Dose)
    Table 51. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
    Table 54. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Dose)
    Table 55. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
    Table 58. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Dose)
    Table 59. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
    Table 62. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Dose)
    Table 63. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
    Table 66. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Dose)
    Table 67. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
    Table 70. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Dose)
    Table 71. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
    Table 74. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Dose)
    Table 75. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Dose)
    Table 78. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2023-2028) & (K Dose)
    Table 79. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
    Table 82. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Dose)
    Table 83. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
    Table 86. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Dose)
    Table 87. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
    Table 90. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Dose)
    Table 91. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
    Table 94. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Dose)
    Table 95. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
    Table 98. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Dose)
    Table 99. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
    Table 102. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Dose)
    Table 103. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 105. MSD Corporation Information
    Table 106. MSD Description and Major Businesses
    Table 107. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 108. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. MSD Recent Developments
    Table 110. Sanofipasteur Corporation Information
    Table 111. Sanofipasteur Description and Major Businesses
    Table 112. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 113. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Sanofipasteur Recent Developments
    Table 115. CDIBP Corporation Information
    Table 116. CDIBP Description and Major Businesses
    Table 117. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 118. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. CDIBP Recent Developments
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
    Table 123. 23-Valent Pneumococcal Polysaccharide Vaccine Customers List
    Table 124. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
    Table 125. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
    Table 126. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
    Table 127. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Product Picture
    Figure 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Single Dose Vial Product Picture
    Figure 4. Pre-filled Syringe Product Picture
    Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application in 2021 & 2028
    Figure 6. For Children (2-10)
    Figure 7. For Person (10-64)
    Figure 8. For The Old (Above or equal to 65)
    Figure 9. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
    Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2028 (K Dose)
    Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2028 (US$ Million)
    Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
    Figure 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2023-2028)
    Figure 16. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2017-2028) & (K Dose)
    Figure 17. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2017-2028) & (K Dose)
    Figure 19. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2017-2028) & (K Dose)
    Figure 21. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2017-2028) & (K Dose)
    Figure 23. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2017-2028) & (K Dose)
    Figure 25. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine in the World: Market Share by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2021
    Figure 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    Figure 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    Figure 33. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 34. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    Figure 35. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 36. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    Figure 37. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country (2017-2028)
    Figure 38. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2017-2028)
    Figure 39. U.S. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 42. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    Figure 43. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 44. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    Figure 45. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country (2017-2028)
    Figure 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2017-2028)
    Figure 47. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 48. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Region (2017-2028)
    Figure 58. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 61. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 68. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 70. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country (2017-2028)
    Figure 72. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2017-2028)
    Figure 73. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2017-2028)
    Figure 82. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 85. 23-Valent Pneumococcal Polysaccharide Vaccine Value Chain
    Figure 86. 23-Valent Pneumococcal Polysaccharide Vaccine Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
MSD
Sanofipasteur
CDIBP
Frequently Asked Questions
23-Valent Pneumococcal Polysaccharide Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
23-Valent Pneumococcal Polysaccharide Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
23-Valent Pneumococcal Polysaccharide Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

HCFCs

HCFCs market is segmented by Type and by Application. Players, stakeholders, and other participan ... Read More

Slurry Separator

Slurry Separator market is segmented by Type and by Application. Players, stakeholders, and other ... Read More

Telehandler Handler

Telehandler Handler market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More